Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for Patients, Seniors and Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a…

Administration Proposal Would Increase Competition, Transparency and Value — Reform Medicare Part D to Protect Seniors and Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing…

Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884…

Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate Rule and Solutions to Hold Big Pharma Accountable and Lower Drug Prices For Immediate Release Contact: Jon Conradi…

Remembering Drug Companies Spend Their Profits on Shareholders and Marketing — And Price Hikes Are Unrelated to Innovation A recent Wall Street Journal article, “Big Pharma Quietly Pushes Back…

Q2 Earnings Reports Continue to Show Pandemic Price Hikes Profitable for Brand Name Drug Makers Another round of second quarter earnings reports from brand name drug makers AstraZeneca, Sanofi, Merck…

Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of Price Hikes During Pandemic Brand name drug makers Pfizer, Bristol Myers Squibb, and GlaxoSmithKline (GSK) held…

Interchangeable Products Will Help Increase Prescription Drug Competition and Provide More Affordable Alternatives For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]…

Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’ Anti-Competitive Tactics Adds to Momentum on Capitol Hill to Lower Rx Prices For Immediate Release Contact: Jon Conradi…